Mesoblast Ltd (MESO)
7.50
+0.21
(+2.88%)
USD |
NASDAQ |
May 03, 16:00
7.495
0.00 (0.00%)
After-Hours: 20:00
Mesoblast Cash from Operations (TTM): -63.27M for June 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
June 30, 2023 | -63.27M |
March 31, 2023 | -60.88M |
December 31, 2022 | -60.10M |
September 30, 2022 | -61.87M |
June 30, 2022 | -65.78M |
March 31, 2022 | -70.81M |
December 31, 2021 | -79.81M |
September 30, 2021 | -118.95M |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 |
Date | Value |
---|---|
September 30, 2019 | |
June 30, 2019 | -57.79M |
March 31, 2019 | -58.89M |
December 31, 2018 | -57.31M |
September 30, 2018 | -74.20M |
June 30, 2018 | -75.01M |
March 31, 2018 | -150.30M |
December 31, 2017 | -84.33M |
September 30, 2017 | -95.00M |
June 30, 2017 | -95.47M |
March 31, 2017 | -18.09M |
December 31, 2016 | -86.49M |
September 30, 2016 | -80.76M |
June 30, 2016 | -88.00M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-118.95M
Minimum
Sep 2021
-57.79M
Maximum
Jun 2019
-71.03M
Average
-63.27M
Median
Jun 2023
Cash from Operations (TTM) Benchmarks
Immuron Ltd | -- |
Alterity Therapeutics Ltd | -10.07M |
Kazia Therapeutics Ltd | -8.366M |
Immutep Ltd | -- |
Opthea Ltd | -- |